PFE·Pfizer Inc.
PFE|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $0.76 | - | - |
| Q2'26 | $0.69 | $0.77 | +11.4% |
| Q1'26 | $0.72 | $0.75 | +3.9% |
| Q4'25 | $0.58 | $0.66 | +14.3% |
| Q3'25 | $0.63 | $0.87 | +37.4% |
| Q2'25 | $0.57 | $0.78 | +35.9% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $16.1B | - | - |
| Q2'26 | $14.5B | $15.0B | +3.3% |
| Q1'26 | $13.8B | $14.5B | +4.7% |
| Q4'25 | $17.1B | $17.6B | +2.6% |
| Q3'25 | - | $16.7B | - |
| Q2'25 | - | $14.7B | - |
PFE|Monthly Returns
Market Data
PFE Stock Snapshot
- Market cap
- 163.52B
- P/E ratio
- 37.7
- Day range
- $28.38 – $28.80
- News sentiment
- 50/100 · Neutral
- Analyst target
- $28.61 (+0.6%)
- Consensus
- Hold · 36 analysts
The setup on Pfizer Inc. is the constructive kind - confirmation across timeframes, not one lone indicator. Earnings and guidance carry more weight than macro data at this capitalisation.
Reverse DCF
What growth is priced into PFE?
At today's price, Pfizer Inc. needs to grow free cash flow about 2.8% a year for the next 10 years to justify its valuation at a 6.66% cost of capital. Over its actual history it has compounded free cash flow at -1.5% a year, so the market is asking for 4.3 percentage points above its own delivered rate. On that basis PFE looks priced above what its own growth record supports.
- Implied FCF growth
- 2.8%
- Historical FCF CAGR
- -1.5%
- Growth gap
- +4.3 pts
- Verdict
- RICH
- Discount rate (WACC)
- 6.66%
- Beta
- 0.61
Behaviour On Record
What PFE's own history says about today's numbers
- Realized volatility (21d)
- 20.2% 59th pct
- Below its peak
- -53.0%
- vs 200-day average
- +9.8%
- Up days (1y)
- 51%
Pfizer Inc. is currently running 20.2% annualised volatility over the last 21 sessions. Measured against PFE's own 13 years of daily returns rather than a market-wide average, that is the 59th percentile — close to its own typical level, against a typical reading of 18.5%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
PFE is trading -53.0% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -20.2%, and the deepest was -48.8% in 2023. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +9.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 89th percentile — a wider gap than this stock usually carries. Over the past year PFE closed higher on 51% of sessions, and it is currently 2 sessions into a falling streak.
On September specifically: over 13 years of records, PFE finished the month higher 7 of 13 times, with a median return of +0.2% and an average of -0.3%. Its strongest month historically has been November at +3.3% on average, its weakest January at -3.2%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: PFE has opened more than 2% away from the prior close in 24 of 3,269 sessions (0.7% of the time), with the largest gaps running +4.3% and -3.7%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, PFE moved an average of 1.8% in the session after earnings, closing higher 2 of those 3 times, with a median move of +1.7% and a largest of +3.8%.
All figures computed from 3,270 daily closes between 2013-09-05 and 2026-09-04, split-adjusted, recomputed daily. Percentiles are against PFE's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of PFE's sector?
Pfizer Inc. sits in the Health Care sector, currently ranked 2nd of 11 GICS sectors by relative-strength rotation score (weakening).
- Sector rank
- #2 of 11
- Sector state
- Weakening
- Sector rotation score
- 90
